United States · Investor

Soleus Capital

Last cheque observed Oct 2026; 5 cheques on record.

Private equityDeploying nowNew fund $1.5B, Aug 2026

SeedSeries ASeries BBiotechMedtechDiagnostics

Deploying now
100%of best year3cheques in 12 months, 5 on record
Since the last cheque11days00hrs00min00sec
Median round$120MRounds led0 of 5
Pitch Soleus Capital

Soleus Capital highlights

  1. 01

    3 cheques in the last 12 months

  2. 02

    Mostly Series B and Series C: 100% of its rounds

What they do

We invest across the healthcare lifecycle from developmental-stage companies through commercial companies.From their own website
Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
BiotechMedtechDiagnostics
Based in
Greenwich, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first5 appearances

  1. 2026

    3 rounds

  2. Oct
    Bolt BiotherapeuticsUS · Pulse 2.0$120MWith 11 others
  3. Oct
    Star TherapeuticsUS · Pulse 2.0$200MWith 10 others
  4. Jul
    Crystalys TherapeuticsSeries B · Frazier Life Sciences$130MWith 10 others
  5. 2019

    1 round

  6. Dec
    ArcherDxSeries C · US · FinSMEs$55MWith 8 others
  7. 2018

    1 round

  8. Sept
    Lyra TherapeuticsSeries B · US · FinSMEs$30MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration10 named

BABenjamin Andrew LundLimited PartneriForm ADV
BJBenoit J. SansoucyDirectoriFiling they signed
DADavid Allen CannerLimited PartneriForm ADV
DCDerek CandyDirectoriFiling they signed
GBGuy Bezalel LevyMr. Levy is the Chief Executive Officer and Chief Investment Officer of the General Partner of the Issuer and the Chief Investment Officer of the Management CompanyiFiling they signed
HJHarold James SchaaffGeneral Counsel; Chief Compliance OfficeriForm ADV
KJKim J. BishopDirectoriFiling they signed
KJKimberly J. MelenDirectoriFiling they signed
MAMichael Anthony CoppolaChief Financial OfficeriForm ADV
SJSteven Joseph MusumeciMr. Musumeci is the Chief Operating Officer of both the General Partner and the Investment Manager CompanyiFiling they signed

We also hold 10 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$3.7Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
Soleus Capital Management, L.P.
SEC number
CRD 294459

Funds on its Form ADV

6 private funds, $2.0B in gross assets · filed Jul 2024

Private equity 4Hedge 2

  1. Soleus Capital Master Fund, L.P.Hedge471 investors$1.6B
  2. Soleus Private Equity Fund III, L.P.Private equity108 investors$195M
  3. Soleus Private Equity Fund II, L.P.Private equity125 investors$181M
  4. Soleus Private Equity Fund I, L.P.Private equity59 investors$25M
  5. Soleus BB SPV, LLCPrivate equity32 investors$8.5M
  6. Soleus Capital Special Opportunities Fund, L.P.Hedge42 investors$7.2M

Who they invest alongside

The investors most often in the same rounds as Soleus Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Soleus Capital put money into.

Quick answers about Soleus Capital

What does Soleus Capital invest in?

Soleus Capital invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Biotech, Medtech and Diagnostics.

How active is Soleus Capital?

5 investments on record, 3 of them in the last 12 months. The most recent was in Oct 2026.

What has Soleus Capital invested in recently?

Its most recent investments on record: Bolt Biotherapeutics (Undisclosed round, Oct 2026), Star Therapeutics (Undisclosed round, Oct 2026) and Crystalys Therapeutics (Series B, Jul 2026).

How big are Soleus Capital's cheques?

The median round it joins is $120M.

Does Soleus Capital lead rounds?

Rarely, if at all: none of its 5 investments on record names it as the lead.

Is Soleus Capital investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

Who does Soleus Capital invest alongside?

Most often ArrowMark Partners (2 rounds together) and Cormorant Asset Management (2 rounds together).

What kind of investor is Soleus Capital?

Soleus Capital is a private equity firm based in Greenwich, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it